Autopsy report · NCT02326155

To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)

Cause of deathNo reason given Automatic label, confidence 0.9, unverified. How labels are made.

“Terminated”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 5 years 3 months before it stopped.
470 participants enrolled.
Results were posted on the registry 2 years after it ended.

Vital statistics

Status: Terminated
Sponsor: Celltrion
Sponsor type: Industry
Conditions: Crohn's Disease; Ulcerative Colitis
Participants: 470

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.